AI in Medicine News ・ 💊 Drug discovery and clinical trials

Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL

PR Newswire · 10/20 12:00 UTC

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) is a computational chemistry company specializing in AI-driven generative design of small molecules. It will take part in the roadshow on the U.S. East Coast.

Read the original (PR Newswire)

See it in the digest → ・ See this issue →